Pyridazinone compounds and uses thereof
US12415794B2 · kind B2 · utility
0Cited by
19References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2021 |
| Grant date | Sep 16, 2025 |
| Priority date | — |
| Expiry date | May 18, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted pyridazinone compounds, conjugates, and pharmaceutical compositions for use in the treatment of neuromuscular diseases, such as Duchenne Muscular Dystrophy (DMD), are disclosed herein. The disclosed compounds are useful, among other things, in the treating of DMD and modulating inflammatory inhibitors IL-1, IL-6 or TNF-α.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.